Rank | Gene Set | Z-score |
---|---|---|
1 | locomotory exploration behavior (GO:0035641) | 6.28629197 |
2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.18795739 |
3 | synaptic vesicle maturation (GO:0016188) | 6.16535775 |
4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.00886170 |
5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.44039202 |
6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.41396670 |
7 | vocalization behavior (GO:0071625) | 5.33996919 |
8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.33293346 |
9 | synaptic vesicle exocytosis (GO:0016079) | 5.28959179 |
10 | glutamate secretion (GO:0014047) | 5.06410760 |
11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.03582001 |
12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.96546472 |
13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.79469163 |
14 | neuronal action potential propagation (GO:0019227) | 4.77923730 |
15 | regulation of synapse structural plasticity (GO:0051823) | 4.77461394 |
16 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.66126120 |
17 | layer formation in cerebral cortex (GO:0021819) | 4.53501703 |
18 | exploration behavior (GO:0035640) | 4.45496615 |
19 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.45367820 |
20 | neurotransmitter secretion (GO:0007269) | 4.39360198 |
21 | protein localization to synapse (GO:0035418) | 4.39273641 |
22 | regulation of synaptic vesicle transport (GO:1902803) | 4.38680396 |
23 | glutamate receptor signaling pathway (GO:0007215) | 4.24767847 |
24 | amino acid import (GO:0043090) | 4.22177761 |
25 | synaptic transmission, glutamatergic (GO:0035249) | 4.21706977 |
26 | dendritic spine morphogenesis (GO:0060997) | 4.14986565 |
27 | cellular potassium ion homeostasis (GO:0030007) | 4.11647096 |
28 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.07576532 |
29 | long-term memory (GO:0007616) | 4.03552090 |
30 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.98457613 |
31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.96286774 |
32 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.94499401 |
33 | gamma-aminobutyric acid transport (GO:0015812) | 3.94252607 |
34 | neuron-neuron synaptic transmission (GO:0007270) | 3.93353984 |
35 | sodium ion export (GO:0071436) | 3.93305925 |
36 | neuromuscular process controlling balance (GO:0050885) | 3.89024093 |
37 | positive regulation of membrane potential (GO:0045838) | 3.88926519 |
38 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.83991616 |
39 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.81936530 |
40 | regulation of postsynaptic membrane potential (GO:0060078) | 3.81143258 |
41 | regulation of synapse maturation (GO:0090128) | 3.71807520 |
42 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.68371853 |
43 | regulation of synaptic plasticity (GO:0048167) | 3.67626935 |
44 | activation of protein kinase A activity (GO:0034199) | 3.64788088 |
45 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.63766212 |
46 | positive regulation of synapse maturation (GO:0090129) | 3.62946796 |
47 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.62896599 |
48 | prepulse inhibition (GO:0060134) | 3.61838317 |
49 | potassium ion homeostasis (GO:0055075) | 3.60185326 |
50 | synaptic vesicle endocytosis (GO:0048488) | 3.56429309 |
51 | regulation of ARF protein signal transduction (GO:0032012) | 3.55708002 |
52 | positive regulation of neurotransmitter transport (GO:0051590) | 3.54085099 |
53 | auditory behavior (GO:0031223) | 3.49838581 |
54 | proline transport (GO:0015824) | 3.46703023 |
55 | regulation of neurotransmitter secretion (GO:0046928) | 3.45424494 |
56 | neuronal ion channel clustering (GO:0045161) | 3.39949662 |
57 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.39765735 |
58 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.39610255 |
59 | neuron cell-cell adhesion (GO:0007158) | 3.39096881 |
60 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.37699514 |
61 | regulation of dendritic spine development (GO:0060998) | 3.35692018 |
62 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.34294805 |
63 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.34002927 |
64 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.33879312 |
65 | neurotransmitter transport (GO:0006836) | 3.31588697 |
66 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.27491989 |
67 | long-term synaptic potentiation (GO:0060291) | 3.26571693 |
68 | membrane depolarization (GO:0051899) | 3.26271073 |
69 | transmission of nerve impulse (GO:0019226) | 3.23494497 |
70 | response to auditory stimulus (GO:0010996) | 3.23260005 |
71 | regulation of neurotransmitter transport (GO:0051588) | 3.19881241 |
72 | regulation of neurotransmitter levels (GO:0001505) | 3.18780325 |
73 | cellular sodium ion homeostasis (GO:0006883) | 3.18060617 |
74 | cerebellar granule cell differentiation (GO:0021707) | 3.16175246 |
75 | positive regulation of dendritic spine development (GO:0060999) | 3.15161987 |
76 | membrane depolarization during action potential (GO:0086010) | 3.14020294 |
77 | L-amino acid import (GO:0043092) | 3.11308821 |
78 | dendrite morphogenesis (GO:0048813) | 3.10926723 |
79 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.09186157 |
80 | membrane hyperpolarization (GO:0060081) | 3.09018445 |
81 | glycine transport (GO:0015816) | 3.07571598 |
82 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.05311854 |
83 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.03969399 |
84 | signal complex assembly (GO:0007172) | 3.03941327 |
85 | behavioral response to cocaine (GO:0048148) | 3.03918173 |
86 | positive regulation of Rap GTPase activity (GO:0032854) | 3.02856611 |
87 | regulation of exocytosis (GO:0017157) | 3.02313775 |
88 | dendritic spine organization (GO:0097061) | 3.01707324 |
89 | vesicle transport along microtubule (GO:0047496) | 3.00347401 |
90 | cell differentiation in hindbrain (GO:0021533) | 3.00323718 |
91 | regulation of vesicle fusion (GO:0031338) | 3.00225420 |
92 | vesicle docking involved in exocytosis (GO:0006904) | 2.98782497 |
93 | neuromuscular process controlling posture (GO:0050884) | 2.98748683 |
94 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.95178656 |
95 | positive regulation of synaptic transmission (GO:0050806) | 2.94351042 |
96 | axon ensheathment in central nervous system (GO:0032291) | 2.94023696 |
97 | central nervous system myelination (GO:0022010) | 2.94023696 |
98 | neuromuscular process (GO:0050905) | 2.92744964 |
99 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.92636161 |
100 | positive regulation of fibroblast migration (GO:0010763) | 2.90714063 |
101 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.90500562 |
102 | regulation of synaptic transmission (GO:0050804) | 2.90137275 |
103 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.88830277 |
104 | learning (GO:0007612) | 2.87344531 |
105 | cell communication by electrical coupling (GO:0010644) | 2.86702858 |
106 | long term synaptic depression (GO:0060292) | 2.86564938 |
107 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.86555027 |
108 | neuron recognition (GO:0008038) | 2.83361999 |
109 | establishment of synaptic vesicle localization (GO:0097480) | 2.81894052 |
110 | synaptic vesicle transport (GO:0048489) | 2.81894052 |
111 | response to histamine (GO:0034776) | 2.81694434 |
112 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.81173713 |
113 | potassium ion import (GO:0010107) | 2.80796028 |
114 | acidic amino acid transport (GO:0015800) | 2.80659159 |
115 | mechanosensory behavior (GO:0007638) | 2.80626513 |
116 | adenosine receptor signaling pathway (GO:0001973) | 2.80390231 |
117 | regulation of Rap GTPase activity (GO:0032317) | 2.73020183 |
118 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.71789746 |
119 | positive regulation of exocytosis (GO:0045921) | 2.69165861 |
120 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.65427619 |
121 | vesicle docking (GO:0048278) | 2.64435919 |
122 | neurotransmitter uptake (GO:0001504) | 2.63450159 |
123 | signal release (GO:0023061) | 2.60131070 |
124 | dicarboxylic acid transport (GO:0006835) | 2.59848746 |
125 | postsynaptic membrane organization (GO:0001941) | 2.59767729 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.61887809 |
2 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.19801506 |
3 | DROSHA_22980978_ChIP-Seq_HELA_Human | 3.03798248 |
4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.96115166 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.93891759 |
6 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.93704110 |
7 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.78567518 |
8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.71226829 |
9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.71226829 |
10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.69494104 |
11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.65471687 |
12 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.61355936 |
13 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.57312818 |
14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.55276279 |
15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.51021494 |
16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.48485672 |
17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.47585400 |
18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.33763815 |
19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.31603770 |
20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.20192229 |
21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.17381898 |
22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.15540348 |
23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.11631656 |
24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.08387507 |
25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.85192623 |
26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.83177851 |
27 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.80184445 |
28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.72607080 |
29 | KDM2B_26808549_Chip-Seq_K562_Human | 1.66595492 |
30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.65938395 |
31 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.63882826 |
32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.61803864 |
33 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.57061892 |
34 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.54312407 |
35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.52144744 |
36 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.51953965 |
37 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.51653168 |
38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.50513308 |
39 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.44882942 |
40 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.43623751 |
41 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.41693956 |
42 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.41505466 |
43 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.41209704 |
44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.39763445 |
45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39660090 |
46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39362990 |
47 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.33286348 |
48 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.32830671 |
49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29560934 |
50 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28903847 |
51 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.28000344 |
52 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26778774 |
53 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.22935107 |
54 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.22061833 |
55 | * AR_19668381_ChIP-Seq_PC3_Human | 1.21755062 |
56 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.21345846 |
57 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.19959821 |
58 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19055817 |
59 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18987863 |
60 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.17406947 |
61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16018738 |
62 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.14773224 |
63 | TP53_16413492_ChIP-PET_HCT116_Human | 1.13741938 |
64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.13378802 |
65 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.12747718 |
66 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.12170925 |
67 | P68_20966046_ChIP-Seq_HELA_Human | 1.11956994 |
68 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.11580795 |
69 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.10693799 |
70 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.10179077 |
71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09478883 |
72 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08507204 |
73 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.08261679 |
74 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08027832 |
75 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.06890752 |
76 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06823715 |
77 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06307885 |
78 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06175668 |
79 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.05567116 |
80 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05453687 |
81 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04052355 |
82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03997366 |
83 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.03108785 |
84 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03096768 |
85 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.02633822 |
86 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.00621529 |
87 | MYC_22102868_ChIP-Seq_BL_Human | 1.00617922 |
88 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.98984005 |
89 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98324376 |
90 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98203134 |
91 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97859418 |
92 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.97331963 |
93 | AR_25329375_ChIP-Seq_VCAP_Human | 0.97124502 |
94 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94410792 |
95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94267739 |
96 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94144136 |
97 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94028418 |
98 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.93720219 |
99 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.93671778 |
100 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93312151 |
101 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.93112795 |
102 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93051078 |
103 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92580469 |
104 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.92416334 |
105 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.91605090 |
106 | TCF4_23295773_ChIP-Seq_U87_Human | 0.91294607 |
107 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.91248533 |
108 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90960949 |
109 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.90514366 |
110 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.90381437 |
111 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90279142 |
112 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.89582455 |
113 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.89517003 |
114 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89256948 |
115 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88890960 |
116 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.88750254 |
117 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.88425753 |
118 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88272119 |
119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88024532 |
120 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.86632704 |
121 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86514805 |
122 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86096365 |
123 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.85212217 |
124 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85151975 |
125 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.85127194 |
126 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84419406 |
127 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84036180 |
128 | SPI1_23127762_ChIP-Seq_K562_Human | 0.83628936 |
129 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.82944643 |
130 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.81605168 |
131 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.81449322 |
132 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.81443734 |
133 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.80304851 |
134 | P300_19829295_ChIP-Seq_ESCs_Human | 0.80031937 |
135 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.79927777 |
136 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79154029 |
137 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.76502683 |
138 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.74280027 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 7.63850017 |
2 | * MP0003635_abnormal_synaptic_transmissio | 4.43724541 |
3 | MP0003880_abnormal_central_pattern | 4.20582275 |
4 | MP0002822_catalepsy | 3.63478133 |
5 | MP0009745_abnormal_behavioral_response | 3.62027729 |
6 | MP0009046_muscle_twitch | 3.59617798 |
7 | MP0004270_analgesia | 3.56848855 |
8 | * MP0002063_abnormal_learning/memory/cond | 3.47538730 |
9 | MP0002064_seizures | 3.29721553 |
10 | MP0002572_abnormal_emotion/affect_behav | 2.82828176 |
11 | MP0001968_abnormal_touch/_nociception | 2.78307838 |
12 | MP0002272_abnormal_nervous_system | 2.57409875 |
13 | MP0001486_abnormal_startle_reflex | 2.56906151 |
14 | MP0000569_abnormal_digit_pigmentation | 2.55082633 |
15 | MP0005423_abnormal_somatic_nervous | 2.53300308 |
16 | MP0001501_abnormal_sleep_pattern | 2.49502868 |
17 | MP0002734_abnormal_mechanical_nocicepti | 2.38247949 |
18 | MP0008569_lethality_at_weaning | 2.31928241 |
19 | MP0001440_abnormal_grooming_behavior | 2.09994015 |
20 | MP0004858_abnormal_nervous_system | 1.98079815 |
21 | MP0003329_amyloid_beta_deposits | 1.97461924 |
22 | MP0002736_abnormal_nociception_after | 1.93025773 |
23 | MP0003879_abnormal_hair_cell | 1.88982676 |
24 | MP0002909_abnormal_adrenal_gland | 1.88405065 |
25 | MP0004811_abnormal_neuron_physiology | 1.88151200 |
26 | MP0002733_abnormal_thermal_nociception | 1.87655272 |
27 | MP0002067_abnormal_sensory_capabilities | 1.87603384 |
28 | MP0001970_abnormal_pain_threshold | 1.83620223 |
29 | MP0009780_abnormal_chondrocyte_physiolo | 1.81732115 |
30 | MP0002735_abnormal_chemical_nociception | 1.79576268 |
31 | MP0004924_abnormal_behavior | 1.72401395 |
32 | MP0005386_behavior/neurological_phenoty | 1.72401395 |
33 | MP0004510_myositis | 1.68729055 |
34 | MP0002557_abnormal_social/conspecific_i | 1.62774838 |
35 | MP0002184_abnormal_innervation | 1.61218528 |
36 | MP0003303_peritoneal_inflammation | 1.52998416 |
37 | MP0003633_abnormal_nervous_system | 1.52604566 |
38 | MP0003075_altered_response_to | 1.51496315 |
39 | MP0000955_abnormal_spinal_cord | 1.41738654 |
40 | MP0002066_abnormal_motor_capabilities/c | 1.37295490 |
41 | MP0003123_paternal_imprinting | 1.37108614 |
42 | MP0004885_abnormal_endolymph | 1.36919584 |
43 | MP0001348_abnormal_lacrimal_gland | 1.36212225 |
44 | MP0000778_abnormal_nervous_system | 1.35656725 |
45 | MP0008260_abnormal_autophagy | 1.30442071 |
46 | MP0000604_amyloidosis | 1.28464393 |
47 | MP0003631_nervous_system_phenotype | 1.27563612 |
48 | MP0008961_abnormal_basal_metabolism | 1.26084459 |
49 | MP0005167_abnormal_blood-brain_barrier | 1.25982676 |
50 | MP0003172_abnormal_lysosome_physiology | 1.23901847 |
51 | MP0002882_abnormal_neuron_morphology | 1.22240340 |
52 | MP0003436_decreased_susceptibility_to | 1.17628001 |
53 | MP0008874_decreased_physiological_sensi | 1.17523077 |
54 | MP0003724_increased_susceptibility_to | 1.16402672 |
55 | MP0001984_abnormal_olfaction | 1.13113769 |
56 | MP0003787_abnormal_imprinting | 1.11960015 |
57 | MP0005646_abnormal_pituitary_gland | 1.11768053 |
58 | MP0003690_abnormal_glial_cell | 1.10651213 |
59 | MP0003705_abnormal_hypodermis_morpholog | 1.09015089 |
60 | MP0008872_abnormal_physiological_respon | 1.03980702 |
61 | MP0002152_abnormal_brain_morphology | 1.03298521 |
62 | MP0003183_abnormal_peptide_metabolism | 1.02938297 |
63 | MP0004145_abnormal_muscle_electrophysio | 1.02376790 |
64 | MP0001502_abnormal_circadian_rhythm | 0.98293602 |
65 | MP0003632_abnormal_nervous_system | 0.96154315 |
66 | MP0003191_abnormal_cellular_cholesterol | 0.95741526 |
67 | MP0001177_atelectasis | 0.90076125 |
68 | MP0004742_abnormal_vestibular_system | 0.89305618 |
69 | MP0004142_abnormal_muscle_tone | 0.85841639 |
70 | MP0003045_fibrosis | 0.85464232 |
71 | MP0000751_myopathy | 0.85181786 |
72 | MP0004147_increased_porphyrin_level | 0.84035559 |
73 | MP0000920_abnormal_myelination | 0.83382441 |
74 | MP0001986_abnormal_taste_sensitivity | 0.83311235 |
75 | MP0001188_hyperpigmentation | 0.80351740 |
76 | * MP0002069_abnormal_eating/drinking_beha | 0.79331521 |
77 | MP0003283_abnormal_digestive_organ | 0.79104256 |
78 | MP0002090_abnormal_vision | 0.77450065 |
79 | MP0005623_abnormal_meninges_morphology | 0.76655389 |
80 | MP0003634_abnormal_glial_cell | 0.75799639 |
81 | MP0002229_neurodegeneration | 0.73564719 |
82 | MP0000013_abnormal_adipose_tissue | 0.72903617 |
83 | MP0003122_maternal_imprinting | 0.72536864 |
84 | MP0009278_abnormal_bone_marrow | 0.72300222 |
85 | * MP0005535_abnormal_body_temperature | 0.71694180 |
86 | MP0005166_decreased_susceptibility_to | 0.71074710 |
87 | MP0002419_abnormal_innate_immunity | 0.70943386 |
88 | MP0010234_abnormal_vibrissa_follicle | 0.67960333 |
89 | MP0001851_eye_inflammation | 0.67363399 |
90 | MP0001905_abnormal_dopamine_level | 0.66953852 |
91 | MP0005645_abnormal_hypothalamus_physiol | 0.66361660 |
92 | MP0004085_abnormal_heartbeat | 0.64991329 |
93 | MP0004130_abnormal_muscle_cell | 0.64611572 |
94 | MP0006082_CNS_inflammation | 0.64414408 |
95 | MP0005409_darkened_coat_color | 0.64162457 |
96 | MP0010386_abnormal_urinary_bladder | 0.64120942 |
97 | MP0005388_respiratory_system_phenotype | 0.63477222 |
98 | MP0002133_abnormal_respiratory_system | 0.63477222 |
99 | MP0005025_abnormal_response_to | 0.63215590 |
100 | MP0005000_abnormal_immune_tolerance | 0.61099570 |
101 | MP0001529_abnormal_vocalization | 0.60808872 |
102 | MP0006276_abnormal_autonomic_nervous | 0.57507208 |
103 | MP0005058_abnormal_lysosome_morphology | 0.57450715 |
104 | MP0001346_abnormal_lacrimal_gland | 0.56409515 |
105 | MP0004947_skin_inflammation | 0.56374275 |
106 | MP0001765_abnormal_ion_homeostasis | 0.52719180 |
107 | MP0003300_gastrointestinal_ulcer | 0.52697731 |
108 | MP0010769_abnormal_survival | 0.52165323 |
109 | MP0004484_altered_response_of | 0.51214077 |
110 | MP0002089_abnormal_postnatal_growth/wei | 0.50518905 |
111 | MP0005174_abnormal_tail_pigmentation | 0.49895076 |
112 | MP0010768_mortality/aging | 0.48912053 |
113 | MP0000015_abnormal_ear_pigmentation | 0.48243305 |
114 | MP0001963_abnormal_hearing_physiology | 0.48210034 |
115 | MP0000747_muscle_weakness | 0.48105929 |
116 | MP0003866_abnormal_defecation | 0.47823869 |
117 | MP0001533_abnormal_skeleton_physiology | 0.47460049 |
118 | MP0002082_postnatal_lethality | 0.47332306 |
119 | MP0010770_preweaning_lethality | 0.47332306 |
120 | MP0001485_abnormal_pinna_reflex | 0.46147735 |
121 | * MP0003956_abnormal_body_size | 0.45137403 |
122 | MP0001943_abnormal_respiration | 0.45049040 |
123 | MP0000681_abnormal_thyroid_gland | 0.42972219 |
124 | MP0004233_abnormal_muscle_weight | 0.42831605 |
125 | MP0002873_normal_phenotype | 0.41954841 |
126 | MP0002083_premature_death | 0.41947580 |
127 | MP0005394_taste/olfaction_phenotype | 0.41330850 |
128 | MP0005499_abnormal_olfactory_system | 0.41330850 |
129 | MP0005187_abnormal_penis_morphology | 0.40642685 |
130 | MP0005310_abnormal_salivary_gland | 0.39146527 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 7.11436532 |
2 | Myokymia (HP:0002411) | 7.01125426 |
3 | Focal seizures (HP:0007359) | 5.89508415 |
4 | Visual hallucinations (HP:0002367) | 5.47037047 |
5 | Action tremor (HP:0002345) | 4.55919119 |
6 | Progressive cerebellar ataxia (HP:0002073) | 4.29773751 |
7 | Epileptic encephalopathy (HP:0200134) | 4.28451880 |
8 | Atonic seizures (HP:0010819) | 4.25377159 |
9 | Febrile seizures (HP:0002373) | 4.16134171 |
10 | Gaze-evoked nystagmus (HP:0000640) | 3.94060487 |
11 | Poor eye contact (HP:0000817) | 3.87631276 |
12 | Absence seizures (HP:0002121) | 3.85282021 |
13 | Papilledema (HP:0001085) | 3.70399182 |
14 | Generalized tonic-clonic seizures (HP:0002069) | 3.67009134 |
15 | Broad-based gait (HP:0002136) | 3.64784162 |
16 | Impaired smooth pursuit (HP:0007772) | 3.49533976 |
17 | Dialeptic seizures (HP:0011146) | 3.46391935 |
18 | Impaired social interactions (HP:0000735) | 3.45476432 |
19 | Abnormal social behavior (HP:0012433) | 3.45476432 |
20 | Supranuclear gaze palsy (HP:0000605) | 3.40620830 |
21 | Dysdiadochokinesis (HP:0002075) | 3.36384631 |
22 | Annular pancreas (HP:0001734) | 3.31155796 |
23 | Ankle clonus (HP:0011448) | 3.27850477 |
24 | Depression (HP:0000716) | 3.24949431 |
25 | Dysmetric saccades (HP:0000641) | 3.24630459 |
26 | Hemiplegia (HP:0002301) | 3.17955848 |
27 | Dysmetria (HP:0001310) | 3.15796532 |
28 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.14969770 |
29 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.09167384 |
30 | Abnormality of ocular smooth pursuit (HP:0000617) | 3.08919098 |
31 | Truncal ataxia (HP:0002078) | 3.07980364 |
32 | Abnormality of the lower motor neuron (HP:0002366) | 3.03546506 |
33 | Genetic anticipation (HP:0003743) | 2.99062207 |
34 | Scanning speech (HP:0002168) | 2.97871400 |
35 | Postural instability (HP:0002172) | 2.95293545 |
36 | Pointed chin (HP:0000307) | 2.93169960 |
37 | Stereotypic behavior (HP:0000733) | 2.92664583 |
38 | Mutism (HP:0002300) | 2.91991430 |
39 | Diplopia (HP:0000651) | 2.87382445 |
40 | Abnormality of binocular vision (HP:0011514) | 2.87382445 |
41 | Anxiety (HP:0000739) | 2.82509177 |
42 | Intention tremor (HP:0002080) | 2.80333607 |
43 | Torticollis (HP:0000473) | 2.77274344 |
44 | Cerebral hypomyelination (HP:0006808) | 2.74604206 |
45 | Hemiparesis (HP:0001269) | 2.74189645 |
46 | Progressive inability to walk (HP:0002505) | 2.64187104 |
47 | Urinary urgency (HP:0000012) | 2.62582792 |
48 | Status epilepticus (HP:0002133) | 2.56112345 |
49 | Slow saccadic eye movements (HP:0000514) | 2.55759468 |
50 | Amblyopia (HP:0000646) | 2.55620681 |
51 | Rigidity (HP:0002063) | 2.52295459 |
52 | Delusions (HP:0000746) | 2.51074191 |
53 | Focal dystonia (HP:0004373) | 2.50145804 |
54 | Resting tremor (HP:0002322) | 2.49637446 |
55 | Rapidly progressive (HP:0003678) | 2.48180680 |
56 | Abnormal eating behavior (HP:0100738) | 2.47681138 |
57 | Peripheral hypomyelination (HP:0007182) | 2.46345050 |
58 | Lower limb amyotrophy (HP:0007210) | 2.43455846 |
59 | Akinesia (HP:0002304) | 2.41850970 |
60 | Drooling (HP:0002307) | 2.37420746 |
61 | Excessive salivation (HP:0003781) | 2.37420746 |
62 | Inappropriate behavior (HP:0000719) | 2.36805108 |
63 | Bradykinesia (HP:0002067) | 2.33471620 |
64 | Spastic gait (HP:0002064) | 2.32580302 |
65 | Neuronal loss in central nervous system (HP:0002529) | 2.32279028 |
66 | Limb dystonia (HP:0002451) | 2.29911126 |
67 | Lower limb asymmetry (HP:0100559) | 2.24612296 |
68 | Impaired vibratory sensation (HP:0002495) | 2.24034238 |
69 | Insomnia (HP:0100785) | 2.22817136 |
70 | Craniofacial dystonia (HP:0012179) | 2.20638542 |
71 | Cerebral inclusion bodies (HP:0100314) | 2.20395524 |
72 | Absent speech (HP:0001344) | 2.19090779 |
73 | Apathy (HP:0000741) | 2.18639942 |
74 | Abnormality of saccadic eye movements (HP:0000570) | 2.18241919 |
75 | Eczematoid dermatitis (HP:0000976) | 2.16903690 |
76 | Obstructive sleep apnea (HP:0002870) | 2.16562407 |
77 | Abnormality of the periventricular white matter (HP:0002518) | 2.16486971 |
78 | Memory impairment (HP:0002354) | 2.15985906 |
79 | Bundle branch block (HP:0011710) | 2.15174935 |
80 | Ankyloglossia (HP:0010296) | 2.15048891 |
81 | Hyperventilation (HP:0002883) | 2.12998806 |
82 | Sleep apnea (HP:0010535) | 2.12701138 |
83 | Ventricular fibrillation (HP:0001663) | 2.06529105 |
84 | Abnormality of the corticospinal tract (HP:0002492) | 2.05797756 |
85 | Spastic tetraparesis (HP:0001285) | 2.05781444 |
86 | Megalencephaly (HP:0001355) | 2.02097592 |
87 | Amyotrophic lateral sclerosis (HP:0007354) | 2.01496366 |
88 | Upper limb amyotrophy (HP:0009129) | 2.01289222 |
89 | Distal upper limb amyotrophy (HP:0007149) | 2.01289222 |
90 | Ocular albinism (HP:0001107) | 2.00866641 |
91 | Neurofibrillary tangles (HP:0002185) | 1.99210781 |
92 | Amyloidosis (HP:0011034) | 1.98958234 |
93 | Epileptiform EEG discharges (HP:0011182) | 1.95957581 |
94 | Spinal canal stenosis (HP:0003416) | 1.95849829 |
95 | Diminished motivation (HP:0000745) | 1.95735096 |
96 | Clonus (HP:0002169) | 1.95438907 |
97 | Gait ataxia (HP:0002066) | 1.94331044 |
98 | Dementia (HP:0000726) | 1.93797736 |
99 | EEG with generalized epileptiform discharges (HP:0011198) | 1.91410129 |
100 | Inability to walk (HP:0002540) | 1.91006127 |
101 | Lower limb muscle weakness (HP:0007340) | 1.86139243 |
102 | Macroorchidism (HP:0000053) | 1.85131234 |
103 | Incomplete penetrance (HP:0003829) | 1.84340793 |
104 | Hypsarrhythmia (HP:0002521) | 1.84072948 |
105 | Choreoathetosis (HP:0001266) | 1.83935777 |
106 | Protruding tongue (HP:0010808) | 1.83166394 |
107 | Postural tremor (HP:0002174) | 1.81662601 |
108 | Cerebral aneurysm (HP:0004944) | 1.81467984 |
109 | Limb ataxia (HP:0002070) | 1.81286109 |
110 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.79356472 |
111 | Iris hypopigmentation (HP:0007730) | 1.79171867 |
112 | Psychosis (HP:0000709) | 1.78485668 |
113 | Intellectual disability, profound (HP:0002187) | 1.76715502 |
114 | Insidious onset (HP:0003587) | 1.76066432 |
115 | Termporal pattern (HP:0011008) | 1.76066432 |
116 | Hyperacusis (HP:0010780) | 1.75406880 |
117 | Tetraplegia (HP:0002445) | 1.75231754 |
118 | Absent frontal sinuses (HP:0002688) | 1.73931496 |
119 | Increased cerebral lipofuscin (HP:0011813) | 1.73695321 |
120 | Achilles tendon contracture (HP:0001771) | 1.73647764 |
121 | Decreased motor nerve conduction velocity (HP:0003431) | 1.71261018 |
122 | Distal sensory impairment (HP:0002936) | 1.69178708 |
123 | Cellulitis (HP:0100658) | 1.68779473 |
124 | Onion bulb formation (HP:0003383) | 1.68719922 |
125 | Slow progression (HP:0003677) | 1.65111071 |
126 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.64358435 |
127 | Hand muscle atrophy (HP:0009130) | 1.64300773 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 5.08405267 |
2 | NTRK3 | 4.03924607 |
3 | MAP3K9 | 3.97628427 |
4 | RIPK4 | 3.46510062 |
5 | CAMKK1 | 2.66479096 |
6 | MAP3K4 | 2.57663810 |
7 | KSR2 | 2.46249761 |
8 | MINK1 | 2.44862794 |
9 | PAK6 | 2.37111981 |
10 | PRKD3 | 2.32968879 |
11 | SIK2 | 2.22197765 |
12 | MARK1 | 2.10271200 |
13 | NTRK2 | 1.98677719 |
14 | CAMKK2 | 1.95204591 |
15 | MAP3K13 | 1.87433597 |
16 | NTRK1 | 1.86394823 |
17 | MAP2K7 | 1.85914768 |
18 | RIPK1 | 1.84836384 |
19 | * DAPK2 | 1.79232245 |
20 | FES | 1.73530054 |
21 | TYRO3 | 1.67676037 |
22 | MAP2K4 | 1.58581113 |
23 | CDK5 | 1.58170843 |
24 | TAOK1 | 1.57568249 |
25 | PRPF4B | 1.51943975 |
26 | LATS2 | 1.51296921 |
27 | KSR1 | 1.50534003 |
28 | STK38 | 1.49608135 |
29 | MAP3K11 | 1.49166048 |
30 | CDK19 | 1.24134772 |
31 | PLK2 | 1.15448833 |
32 | TRIB3 | 1.13384354 |
33 | STK11 | 1.13381469 |
34 | MAP3K2 | 1.12344424 |
35 | TNIK | 1.09457500 |
36 | ARAF | 1.08681016 |
37 | CAMK1 | 1.08026280 |
38 | GRK5 | 1.05936041 |
39 | ALK | 1.03959367 |
40 | PRKCH | 1.03559252 |
41 | RAF1 | 1.01436607 |
42 | PRKCG | 1.01412026 |
43 | PTK2B | 0.99633214 |
44 | RET | 0.99577482 |
45 | * DAPK1 | 0.98776030 |
46 | ERN1 | 0.97867799 |
47 | PINK1 | 0.97345546 |
48 | MAP3K12 | 0.97069594 |
49 | CAMK1G | 0.93871288 |
50 | PDK1 | 0.90307445 |
51 | MAP2K3 | 0.89573983 |
52 | UHMK1 | 0.87115056 |
53 | IRAK2 | 0.86929564 |
54 | MAPK13 | 0.85016052 |
55 | JAK2 | 0.83812416 |
56 | SGK3 | 0.83460610 |
57 | SGK1 | 0.81763321 |
58 | PDPK1 | 0.81272657 |
59 | CDK15 | 0.80594430 |
60 | NEK6 | 0.80041374 |
61 | BMPR2 | 0.78304577 |
62 | CDK18 | 0.78222054 |
63 | TAOK2 | 0.75386816 |
64 | CAMK4 | 0.74016106 |
65 | SMG1 | 0.72505342 |
66 | SCYL2 | 0.71704052 |
67 | MARK2 | 0.70845780 |
68 | SGK2 | 0.70825228 |
69 | CDK14 | 0.70331311 |
70 | CDK11A | 0.69873991 |
71 | SGK494 | 0.68786421 |
72 | SGK223 | 0.68786421 |
73 | TNK2 | 0.67711372 |
74 | WNK1 | 0.67545150 |
75 | PNCK | 0.66490898 |
76 | MAP3K1 | 0.64202580 |
77 | CAMK2A | 0.62011033 |
78 | FYN | 0.61939833 |
79 | FGR | 0.57575342 |
80 | EEF2K | 0.57265717 |
81 | BMX | 0.56918645 |
82 | BRAF | 0.55740323 |
83 | TYK2 | 0.52002579 |
84 | * RPS6KA3 | 0.51314683 |
85 | MAP3K7 | 0.49654687 |
86 | PRKG2 | 0.49287372 |
87 | BLK | 0.49150741 |
88 | ICK | 0.48563658 |
89 | DYRK1A | 0.47735213 |
90 | PRKCZ | 0.47473040 |
91 | MAP4K1 | 0.47311469 |
92 | DMPK | 0.47098798 |
93 | OXSR1 | 0.46943902 |
94 | SYK | 0.46308727 |
95 | CAMK2G | 0.46251383 |
96 | SIK3 | 0.45909503 |
97 | IRAK4 | 0.45348178 |
98 | MAPK10 | 0.45298626 |
99 | PKN2 | 0.43354663 |
100 | CAMK2B | 0.41879688 |
101 | CCNB1 | 0.41844074 |
102 | CDC42BPA | 0.41543493 |
103 | MAPK7 | 0.40927474 |
104 | PHKG1 | 0.40516032 |
105 | PHKG2 | 0.40516032 |
106 | MAPK12 | 0.38494775 |
107 | GRK6 | 0.38261280 |
108 | ROCK2 | 0.36688710 |
109 | HIPK2 | 0.36414859 |
110 | CSNK1G2 | 0.36176694 |
111 | PDGFRA | 0.35617034 |
112 | RPS6KA2 | 0.35000196 |
113 | HCK | 0.34834322 |
114 | CAMK1D | 0.33411584 |
115 | JAK1 | 0.33395662 |
116 | MAP3K6 | 0.32232802 |
117 | PRKCB | 0.31833588 |
118 | MAP2K1 | 0.31751961 |
119 | PAK3 | 0.31014975 |
120 | MAPK8 | 0.30565084 |
121 | PRKD2 | 0.30498047 |
122 | SRC | 0.29258544 |
123 | BRSK1 | 0.28566982 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.02186950 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.81333515 |
3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.75542241 |
4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.64476649 |
5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.53772093 |
6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.49467533 |
7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.36576979 |
8 | Morphine addiction_Homo sapiens_hsa05032 | 2.36127485 |
9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.27165255 |
10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.19301347 |
11 | Salivary secretion_Homo sapiens_hsa04970 | 2.12332349 |
12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.02114971 |
13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.97356109 |
14 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.95247590 |
15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.89042779 |
16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.88435263 |
17 | Insulin secretion_Homo sapiens_hsa04911 | 1.71442838 |
18 | Long-term depression_Homo sapiens_hsa04730 | 1.70779690 |
19 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.69866592 |
20 | Renin secretion_Homo sapiens_hsa04924 | 1.67654454 |
21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62822316 |
22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.50776544 |
23 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.47523939 |
24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.45887329 |
25 | Taste transduction_Homo sapiens_hsa04742 | 1.45013572 |
26 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.44449789 |
27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40898539 |
28 | Glioma_Homo sapiens_hsa05214 | 1.36439049 |
29 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.35540993 |
30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34141161 |
31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.30201527 |
32 | Gap junction_Homo sapiens_hsa04540 | 1.28328236 |
33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.25257745 |
34 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.24354187 |
35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.15622786 |
36 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.11305959 |
37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.10455875 |
38 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.06304059 |
39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05444802 |
40 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.05056690 |
41 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02167662 |
42 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.00671475 |
43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.97839149 |
44 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.97802417 |
45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.96142707 |
46 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.94944078 |
47 | Prion diseases_Homo sapiens_hsa05020 | 0.92929892 |
48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.92000014 |
49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91605874 |
50 | Melanogenesis_Homo sapiens_hsa04916 | 0.91132588 |
51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90532744 |
52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.86752083 |
53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86083063 |
54 | Axon guidance_Homo sapiens_hsa04360 | 0.84355818 |
55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84253829 |
56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.83587425 |
57 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81063145 |
58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79985232 |
59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78694085 |
60 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78226486 |
61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77963557 |
62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76713139 |
63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.76649460 |
64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76397523 |
65 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76001330 |
66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73134204 |
67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69778118 |
68 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68774260 |
69 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.67988598 |
70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67298764 |
71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66718946 |
72 | Platelet activation_Homo sapiens_hsa04611 | 0.66111411 |
73 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63390824 |
74 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.62286487 |
75 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.62283630 |
76 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.61051551 |
77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60398497 |
78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60319959 |
79 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.60231924 |
80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.59935522 |
81 | Endocytosis_Homo sapiens_hsa04144 | 0.59398672 |
82 | Leishmaniasis_Homo sapiens_hsa05140 | 0.59280838 |
83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55144076 |
84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55030078 |
85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54064852 |
86 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.53717921 |
87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52504403 |
88 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50322640 |
89 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.50071205 |
90 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49757602 |
91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49633047 |
92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49604305 |
93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47400704 |
94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47072745 |
95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46743041 |
96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46576302 |
97 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46277431 |
98 | Tuberculosis_Homo sapiens_hsa05152 | 0.45966681 |
99 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.45335452 |
100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45116731 |
101 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.44779062 |
102 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.43203765 |
103 | * Alcoholism_Homo sapiens_hsa05034 | 0.41670006 |
104 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.40772131 |
105 | Bile secretion_Homo sapiens_hsa04976 | 0.40286810 |
106 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.38487615 |
107 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37988673 |
108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37737677 |
109 | Amoebiasis_Homo sapiens_hsa05146 | 0.37350888 |
110 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.37313758 |
111 | Salmonella infection_Homo sapiens_hsa05132 | 0.36469388 |
112 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36114921 |